Table 1.
Characteristics of the sample.
| Unvaccinated a | 1 Dose b | 2 Dose c | 3/4 Dose d | |
|---|---|---|---|---|
| (n = 290,727) | (n = 245,741) | (n = 234,287) | (n = 186,684) | |
| Age in years (Mean, SD) | 48.9 (20.8) | 49.7 (20.7) | 50.1 (20.7) | 52.5 (20.2) |
| Gender (n,%) | ||||
| Females | 148,770 (51.2) | 127,121 (51.7) | 121,516 (51.9) | 97,440 (52.2) |
| Males | 141,957 (48.8) | 118,620 (48.3) | 112,771 (48.1) | 89,244 (47.8) |
| Risk factors and comorbidities (n,%) | ||||
| Hypertension | 40,255 (13.8) | 37,003 (15.1) | 36,159 (15.4) | 32,264 (17.3) |
| Diabetes | 15,599 (5.4) | 14,224 (5.8) | 13,837 (5.9) | 12,282 (6.6) |
| CVD | 23,252 (8) | 20,940 (8.5) | 19,991 (8.5) | 17,321 (9.3) |
| Kidney disease | 5431 (1.9) | 4718 (1.9) | 4568 (1.9) | 3793 (2) |
| Cancer | 16,580 (5.7) | 15,065 (6.1) | 14,676 (6.3) | 12,810 (6.9) |
| Infection | 117,559 (40.4) | 104,397 (42.5) | 97,102 (41.4) | 69,637 (37.3) |
| COPD | 11,035 (3.8) | 9802 (4) | 9391 (4) | 7683 (4.1) |
SD = Standard deviation. a In this group were inserted never-vaccinated and vaccinated individuals before receiving one or more doses; b in this group were inserted all individuals vaccinated with 1 dose and all individuals vaccinated before receiving 2 or more doses; c in this group were inserted all individuals vaccinated with 2 doses and all individuals vaccinated before receiving 2 or more doses; d in this group were inserted all individuals vaccinated with 3 or more doses.